Both c-Myc and PHB1 directly interact with Nrf2 but c-Myc lowers Nrf2 binding to ARE while PHB1 enhances it. Innovation: This JQ1 Epigenetics inhibitor is the first work that shows how activation of this circuit in cholestatic liver injury

inhibits GCL expression. Conclusions: LCA feeding and BDL activate c-Myc-miR27a/b-PHB1 circuit, with the consequence of inhibiting Nrf2 expression and ARE binding, resulting in decreased reduced glutathione synthesis and antioxidant capacity. Antioxid. Redox Signal. 22, 259-274.”
“Purpose: To establish a first-order derivative ultraviolet spectrophotometric (FODUS) method with good reproducibility for the determination of levan, a D-fructofuranosyl polymer with a beta-(2-6) backbone and beta-(2-1) branching. Methods: Levan was isolated from fermentation broth by alcohol precipitation and ultrafiltration. Factors influencing the determination of the ultraviolet (UV) spectrophotometric method was compared with a single-factor analysis. The UV spectra of levan reaction solutions in the absorbance range of 200 – 400 nm were obtained. An orthogonal experimental design was applied to optimize the sulfuric acid hydrolysis conditions in the spectrophotometric

determination. FODUS method was validated by analyzing its linearity, reproducibility, stability and recovery. Results: Factors influencing absorbance for the determination were confirmed and two regression MK-2206 equations were established. UV absorbance at 320 nm GW-572016 of sulfuric acid-hydrolyzed sample was stable for 5 h. The FODUS method developed had a good reproducibility (RSD = 2.1 %, n = 5), linearity (ranging from 1.6 mu g/mL to 12.8 mu g/mL), R-2 = 0.9996) and recovery (95.90 %, RSD = 1.7 %, n = 3). Conclusion: The developed FODUS method is convenient, efficient and robust for the determination of microbial levan.

The method provides a valuable approach for the determination of polysaccharides.”
“In a companion article to this study,1 the successful programming of a JAWSII dendritic cell (DC) line’s antigen uptake and processing was demonstrated based on pre-treatment of DCs with a specific cocktail’ of select chemokines. Chemokine pre-treatment modulated cytokine production before and after DC maturation [by lipopolysaccharide (LPS)]. After DC maturation, it induced an antigen uptake and processing capacity at levels 36% and 82% higher than in immature DCs, respectively. Such programming proffers a potential new approach to enhance vaccine efficiency. Unfortunately, simply enhancing antigen uptake does not guarantee the desired activation and proliferation of lymphocytes, e.g. CD4+ T cells.